HALO logo
halo search icon
095700
Genexine, Inc.

095700 · Genexine, Inc.

3325.00

KRW
325.00 (10.83%)
21/08/2026 12:00:00 AM
+1
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

KRW136.62B

PE

0.00

EV/EBITDA

N/A

DIV Yield

0%

Payout Ratio

0%

MQV Rating

5Very Weak

As at 21/08/2026 12:00:00 AM

Price Chart

Description

Genexine, Inc. engages in research and development of novel immunotherapies for cancer and antibody therapies for rare diseases. Its pipeline of medicines is built upon its proprietary technologies, the hyFc and DNA vaccine platforms. The hyFc platform technology is used for development of long-acting protein drugs, maximizing the half-life of drugs in the human body through fusion with various drugs. The DNA vaccine platform inserts a genetic fragment involved in protein production into a vaccine, eliciting immune responses in the human body to fight viral infection and cancer cells. The company was founded by Young Chul Sung on June 8, 1999 and is headquartered in Seoul, South Korea.

  • All-Companies
  • Big Candle
  • HALO All
  • Volume Spike

Key Fundamentals

EPS 3 yr Growth

-54.60%

EBITDA Margin

-634.90%

Operating Cashflow

-₩29,584m

Free Cash Flow Return

-10.90%

ROIC

-10.00%

Interest Coverage

-11.90

Quick Ratio

0.40

Performance

52 weeks range

Low 2140 - 7490

Trade Value (12mth)

US$290,024.00

1 week

0%

1 month

28.21%

YTD

-38.65%

1 year

-39.82%

All time high

136719.00

Additional Data

Shares Outstanding (Fully Diluted)

45m

HALO Sector

Healthcare

Next Company Report Date

N/A

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

KRW

Short Sell (% of issue)

0.00

Consensus

Lock Icon

Unlock full consensus

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

Valuation

Lock Icon

Unlock full dataset

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

Key Stakeholders

NameTitle
Handok, Inc.Public Company
Young-Chul SungIndividual
Jae-Hyun ChoiIndividual
Seung-hyun LeeIndividual
Yu-Seok SeoIndividual

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial
Want to learn more?Frequently asked questions.
1
What is the current share price of Genexine, Inc. (095700:KRX)?
Halo FAQ
The current share price of Genexine, Inc. (095700:KRX) is KRW₩3325.00.
2
What is the 52-week high share price for Genexine, Inc. (095700:KRX)?
Halo FAQ
The 52-week high share price for Genexine, Inc. (095700:KRX) is KRW₩7490.00.
3
What is the 52-week low share price for Genexine, Inc. (095700:KRX)?
Halo FAQ
The 52-week low share price for Genexine, Inc. (095700:KRX) is KRW₩2140.00.
4
What is the dividend yield for Genexine, Inc. (095700:KRX)?
Halo FAQ
Genexine, Inc. (095700:KRX) does not pay a dividend.
5
What was Genexine, Inc. (095700:KRX) last dividend payment?
Halo FAQ
Genexine, Inc. (095700:KRX) does not pay a dividend.
6
What is the franking level for Genexine, Inc. (095700:KRX)?
Halo FAQ
Genexine, Inc. (095700:KRX) has a franking level of 0.00%.
7
In which sector is Genexine, Inc. (095700:KRX) classified?
Halo FAQ
Genexine, Inc. (095700:KRX) is classified in the Healthcare.